Adwia Scientific Office in Egypt: Advancing Health Solutions for Animals and Humans
- Adwia Scientific Office address: Obour City, 1st ind. zone. Block 13007. P.O. Box 59, Cairo.
- Tel.: 02 261 00 655.
- Tel.: 02 261 00 667.
- Fax: 02-261-00-663.
- #scientific_office.
Adwia, a leading Egyptian pharmaceutical company, has been at the forefront of delivering cutting-edge healthcare solutions since its establishment in 1984. With a mission to bring the latest technologies and international expertise to the local market, Adwia has made significant contributions to the healthcare sector in Egypt. In this blog post, we will explore the role and offerings of Adwia's Scientific Office located in New Cairo, highlighting its commitment to improving animal and human health through a diverse range of products.
A
Comprehensive Range of Health Products
Adwia has cemented its position as a key player
in the Egyptian production market by offering a wide range of health products
that cater to various diseases across all animal species. The company's
extensive portfolio includes analgesic products, anti-infective products,
cardiovascular products, central nervous system products, dermatological
products, gastrointestinal products, genito-urinary products, gynecological
products, musculoskeletal products, and respiratory products. Adwia's diverse
product offerings reflect its dedication to addressing the unique healthcare
needs of animals in Egypt.
Advancing
Animal Health
Since its inception in 1988, Adwia has been
committed to enhancing animal health and welfare. The company's focus on
producing, marketing, and distributing health products for animals has played a
crucial role in supporting Egypt's agricultural sector. By providing effective solutions
for various animal diseases, Adwia has contributed to the growth and
sustainability of animal production in the country. The Scientific Office in
New Cairo serves as a hub for research and development, ensuring that Adwia
remains at the forefront of veterinary innovation.
Strategic
Investment for Growth
In 2020, Adwia underwent a significant
milestone when it was acquired by an investment platform created by the
European Bank for Reconstruction and Development (EBRD), Development Partners
International (DPI), and CDC Group. This strategic investment aims to propel
Adwia's growth and modernization initiatives. The infusion of capital will
enable the company to expand its manufacturing capabilities, introduce
high-value-added products, enhance health and safety standards, improve product
quality, and strengthen corporate governance in Egypt. This partnership
demonstrates the recognition of Adwia's potential and the confidence in its
ability to shape the future of the pharmaceutical industry in Egypt.
Aligning
International Expertise with Local Needs
Adwia's Scientific Office in New Cairo serves
as a bridge between international expertise and the local market. The company's
mission to bring the latest technologies and know-how to Egypt is a testament
to its commitment to delivering innovative healthcare solutions. By leveraging
global insights, Adwia aims to develop products and therapies that are tailored
to the specific needs of Egyptian patients and animals. This approach ensures
that Adwia remains at the forefront of scientific advancements, empowering healthcare
professionals with the tools they need to provide the best possible care.
Conclusion
Adwia's Scientific Office in Egypt plays a
vital role in advancing healthcare solutions for animals and humans. With a
rich history of innovation and a diverse range of health products, Adwia
continues to make a significant impact on the local pharmaceutical industry.
Through its strategic partnerships and investments, the company is poised for
further growth and modernization, enabling it to bring cutting-edge treatments
and therapies to the market. Adwia's commitment to international expertise and
local needs positions it as a key player in shaping the future of healthcare in
Egypt.
Sources:
1.
Adwia. https://adwia.com/.
2.
EBRD and partners acquire
Egypt's Adwia Pharmaceuticals. https://www.ebrd.com/news/2020/ebrd-and-partners-acquire-egypts-adwia-pharmaceuticals.html.
3.
DPI on its big Adwia investment
+ why it likes Egypt right now. https://enterprise.press/stories/2020/12/10/dpi-on-its-big-adwia-investment-why-it-likes-egypt-right-now-26964/.
4. Adwia Company Profile: Acquisition & Investors | PitchBook. https://pitchbook.com/profiles/company/144714-79.
عن الكاتب
الدكتور أحمد باكر، دكتور صيدلة
صيدلي أول ومثقف صحي بخبرة واسعة. يهدف الدكتور أحمد إلى تقديم معلومات صحية موثوقة تستند إلى الأدلة العلمية وتبسيط المفاهيم الطبية للجميع.
إخلاء المسؤولية القانونية
المعلومات المقدمة هي لأغراض تعليمية فقط ولا تغني عن استشارة الطبيب المختص.
تعليقات
إرسال تعليق